Sydney Ch'ng1,2,3, Richard A Scolyer4,5,6, John F Thompson4,5,6. 1. Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, 2040, Australia. sydney.chng@sydney.edu.au. 2. Royal Prince Alfred Hospital, Camperdown, NSW, Australia. sydney.chng@sydney.edu.au. 3. Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. sydney.chng@sydney.edu.au. 4. Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, 2040, Australia. 5. Royal Prince Alfred Hospital, Camperdown, NSW, Australia. 6. Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Authors: Andrew T Li; Kavita Vakharia; Serigne N Lo; Alexander H R Varey; Matteo S Carlino; Robyn P M Saw; Kerwin F Shannon; Julie R Howle; Thomas E Pennington; Jonathan R Stretch; Omgo E Nieweg; Andrew J Spillane; Georgina V Long; Alexander M Menzies; Richard A Scolyer; John F Thompson; Sydney Ch'ng Journal: Ann Surg Oncol Date: 2021-08-04 Impact factor: 5.344